1. Cancer statistics;Landis;CA Cancer J. Clin.,1999
2. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody;Milas;Clin. Cancer Res.,2000
3. Tyrosine kinase inhibitors-ZD1839 (Iressa);Arteaga;Curr. Opin. Oncol.,2001
4. A pilot trial demonstrates the safety of ZD1839 (Iressa), an oral epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), in combination with carboplatin (C) and paclitaxel (P) in previously untreated advanced non-small cell lung cancer;Miller;Proc. Am. Soc. Clin. Oncol.,2001
5. The EGF receptor: structure, regulation and potential role in malignancy;Thompson;Cancer Surv.,1985